Canada Pension Plan Investment Board acquired a new stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 600,117 shares of the semiconductor company’s stock, valued at approximately $267,694,000.
Other large investors also recently bought and sold shares of the company. BlackRock Inc. purchased a new position in Synopsys in the 2nd quarter worth about $7,228,099,000. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new stake in shares of Synopsys during the 2nd quarter valued at about $747,400,000. Norges Bank purchased a new stake in shares of Synopsys during the 4th quarter valued at about $730,197,000. Bank of New York Mellon Corp bought a new stake in shares of Synopsys in the second quarter worth approximately $692,074,000. Finally, State Street Corp raised its holdings in shares of Synopsys by 20.6% during the third quarter. State Street Corp now owns 8,760,358 shares of the semiconductor company’s stock valued at $4,322,273,000 after purchasing an additional 1,493,912 shares during the last quarter. 85.47% of the stock is currently owned by institutional investors.
Synopsys Price Performance
Shares of NASDAQ:SNPS opened at $408.79 on Wednesday. The company has a quick ratio of 1.32, a current ratio of 1.43 and a debt-to-equity ratio of 0.33. The stock has a market capitalization of $78.28 billion, a PE ratio of 94.63, a price-to-earnings-growth ratio of 2.32 and a beta of 1.23. The firm’s 50 day moving average price is $417.74 and its 200-day moving average price is $439.85. Synopsys, Inc. has a twelve month low of $366.00 and a twelve month high of $615.79.
Analyst Ratings Changes
A number of research analysts recently weighed in on SNPS shares. Berenberg Bank set a $633.00 price objective on shares of Synopsys in a research report on Wednesday, May 27th. Robert W. Baird set a $558.00 target price on shares of Synopsys in a research report on Thursday, May 28th. Rosenblatt Securities reiterated a “buy” rating and set a $575.00 target price on shares of Synopsys in a research note on Tuesday. KeyCorp reissued an “overweight” rating on shares of Synopsys in a report on Wednesday, August 19th. Finally, BNP Paribas Exane raised their price target on Synopsys from $425.00 to $450.00 and gave the stock an “underperform” rating in a research note on Thursday, May 28th. Eleven research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $563.59.
Check Out Our Latest Stock Report on SNPS
Insider Activity at Synopsys
In other news, CFO Shelagh Glaser sold 3,394 shares of Synopsys stock in a transaction on Friday, June 12th. The shares were sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the transaction, the chief financial officer owned 14,358 shares in the company, valued at $6,461,387.16. This trade represents a 19.12% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the business’s stock in a transaction on Monday, June 15th. The shares were sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the sale, the chief executive officer directly owned 75,020 shares of the company’s stock, valued at approximately $34,431,179.20. The trade was a 16.29% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.56% of the stock is currently owned by company insiders.
About Synopsys
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front?end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape?out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
See Also
- Five stocks we like better than Synopsys
- Pathward’s Credit Scare Tests Its Comeback Story
- Wiring the AI Boom: Rumble’s $13.7B Pivot
- StoneX: Too Far Too Fast?
- DICK’s Sporting Goods Faces Pain Now for a Bigger Prize
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
